Showing results (121-130 of 408) with videos related to
Sort By:
Pageof 41
Clinical Lymphoma|January 8, 2005
Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literatureStephen M Ansell, Russell J Schilder, Peter C Pieslor, et al.American Journal of Hematology|April 10, 2014
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom MacroglobulinemiaIrene M Ghobrial, Thomas E Witzig, Morie Gertz, et al.Hematological Oncology|October 25, 2023
Dependence of peripheral T-cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approachKang Le, Jordan Vollenweider, JingJing Han, et al.Cancer|May 26, 2004
High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosisIrene M Ghobrial, Francis Buadi, Robert J Spinner, et al.British Journal of Haematology|November 20, 2002
Bone marrow angiogenesis in multiple myeloma: effect of therapyShaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphomaEmilian Racila, Brian K Link, Wen-Kai Weng, et al.International Journal of Cardiology|October 16, 2018
Acute coronary syndromes in patients with active hematologic malignancies - Incidence, management, and outcomesJae Yoon Park, Wei Guo, Mohammed Al-Hijji, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significanceShaji Kumar, S Vincent Rajkumar, Robert A Kyle, et al.Annals of the Rheumatic Diseases|February 11, 2015
Rituximab for IgG4-related disease: a prospective, open-label trialMollie N Carruthers, Mark D Topazian, Arezou Khosroshahi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopyThomas E Witzig, Blaise Bossy, Teresa Kimlinger, et al.Pageof 41